Simplex in Biological Technology

Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes

... keratitis, an ocular disease caused by the herpes simplex virus. The FDA has issued an action date in late ... ) "Herpes simplex keratitis remains one of the leading causes of ... About Herpetic Keratitis Herpes simplex virus (HSV) infections are very common, with ...

CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses

... that result initiate a protective cell mediated and antibody immune response. These results were obtained for L.E.A.P.S. vaccines against herpes simplex and HIV. The L.E.A.P.S. technology is a novel T-cell modulation platform technology that enables CEL-SCI to design and synthesize proprietary ...

CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology

... several different L.E.A.P.S. conjugates induced protection and/or improvement in diseases as diverse as rheumatoid arthritis, malaria, TB and herpes simplex viruses. This shows that the L.E.A.P.S. technology can be successfully applied to many different diseases and these results further suggest that ....

China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs

... in China for two of its newly developed drugs. Acyclovir gel is used to treat the skin infection due to varicella-zoster virus and the herpes simplex virus. Shuanghuanglian suppositories helps relieve cold and flu symptoms such as fever, cough and sore throat pain. It can also be used to treat ...

LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record

... Profectus' broad product pipeline will address Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Human Papilloma Virus (HPV) and Herpes simplex Virus (HSV). The Profectus portfolio has received over $100 million in funding from multiple sources including National Institutes of Health ...

CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies

... L.E.A.P.S. technology combines a small peptide that activates the immune system with a small peptide from a disease-related protein, such as a herpes simplex virus (HSV) glycoprotein, to make a vaccine that induces a defined immune response. The Company hopes to commence clinical trials in humans in order ...

CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease

... L.E.A.P.S. technology combines a small peptide that activates the immune system with a small peptide from a disease-related protein, such as a herpes simplex virus (HSV) glycoprotein to make a vaccine that induces a defined immune response. Dr. Kenneth S. Rosenthal, Professor of Microbiology, Immunology ...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

... response. Researchers have found that PS is exposed on the outer membrane of cells infected with HIV, influenza (including avian flu), herpes simplex viruses, hemorrhagic fever viruses, measles and members of the small pox and rabies virus families. Dr. Barton Haynes, director of Duke ...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

... response. Researchers have found that PS is exposed on the outer membrane of cells infected with HIV, influenza (including avian flu), herpes simplex viruses, hemorrhagic fever viruses, measles and members of the small pox and rabies virus families. Dr. Barton Haynes, director of Duke ...

NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008

... Presentation #V-3539 12:15 p.m. - 1:15 p.m. NB-001, A Novel Nanoemulsion Active Against Acyclovir (ACV)- and Foscarnet (FOS)-Resistant Herpes simplex Virus (HSV) 1 and 2, Poster #V-3538 Tuesday, October 28, 2008 9:00 a.m. - 9:15 a.m. Oral Presentation: Subject-Assessed Time to Healing in a ...

Company's Partner Completes Trial Production of a New Antiviral Medicine

... of a new antiviral product. This all-natural medicine has been approved in China for external use to treat human papillomavirus ("HPV") and herpes simplex virus ("HSV"). Tests have shown an inhibitory effect on the growth of HPV and HSV, and the medicine can reduce the infection from HPV and HSV up to ...

Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum

... major active ingredients which have anti-Herpes simplex virus type 1 properties. While other methods are ... herb Taraxacum mongolicum have anti-Herpes simplex virus type-1 properties in vitro. Using liquid ... mongolicum. Since this herb has anti-Herpes simplex virus type-1 properties, the nucleoside analogs ...

UW-Madison spinoff Pedrus finds more to business planning than good science

... says, "keeping the barbarians at the gate." "For the STDs, there are currently no acceptable drugs on the market for blocking HIV and HSV [herpes simplex virus]," Brandt said. "The complex that was being used has been shown to actually enhance your ability to catch these STDs. ... There's a big problem ...

UW compound counters Avian flu

... that discovered this compound had observed its flu-fighting capabilities after finding that similar peptides could prevent infection by the herpes simplex virus. It is not the same team led by UW-Madison professor of virology Yoshihiro Kawaoka, who will direct the UW's Institute for Influenza Viral ...

Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities

... Geschwind, M. D., et al., Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector, Brain Res. Mol. Brain Res., 24 , 327335 (1994) ...

New PCR Primers for Human Diseases

... Human immunodeficiency virus, type 1 (HIV-1), 1,2 hepatitis B (HBV), 3 hepatitis C (HCV) (RT-PCR primers*, use cDNA as template), 4,5 herpes simplex virus, types 1 and 2 (HSV-1, HSV-2), 6-8 human herpesvirus 6 (HHV-6), 9,10 parvovirus B19, 11 genital human papillomavirus (HPV), 12-14 ...

HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex Virus DNA

... Stratagene introduces the HSVision molecular beacon detection module, * , , ff a single-tube method to quickly detect HSV (herpes simplex virus) DNA. Because it is performed in a closed-tube system and requires no postamplification manipulation, HSV detection is simplified, and the ...